The suspension from Nasdaq for Windtree Therapeutics (ticker WINT), due to non-compliance with listing requirements and accompanied by an intraday collapse of –80%, has sparked strong fears among investors and raised questions about the recent initiative of treasury in $BNB (initial commitment of $60 million with potential up to $200 million), indicating an already fragile financial balance.
According to the collected data, the stock went from about $0.48 before the notice to $0.11 at the close on August 21, 2025, confirming the very substantial intraday loss. Industry analysts monitoring small-cap biotech companies note that similar situations typically lead to a compression of capitalization and a significant reduction in liquidity in the first weeks following the delisting.
WINT quotes by TradingView
{ “lineWidth”: 2, “lineType”: 0, “chartType”: “candlesticks”, “showVolume”: true, “fontColor”: “rgb(106, 109, 120)”, “gridLineColor”: “rgba(242, 242, 242, 0.06)”, “volumeUpColor”: “rgba(34, 171, 148, 0.5)”, “volumeDownColor”: “rgba(247, 82, 95, 0.5)”, “backgroundColor”: “#0F0F0F”, “widgetFontColor”: “#DBDBDB”, “upColor”: “#22ab94”, “downColor”: “#f7525f”, “borderUpColor”: “#22ab94”, “borderDownColor”: “#f7525f”, “wickUpColor”: “#22ab94”, “wickDownColor”: “#f7525f”, “colorTheme”: “dark”, “isTransparent”: false, “locale”: “en”, “chartOnly”: false, “scalePosition”: “right”, “scaleMode”: “Normal”, “fontFamily”: “-apple-system, BlinkMacSystemFont, Trebuchet MS, Roboto, Ubuntu, sans-serif”, “valuesTracking”: “1”, “changeMode”: “price-and-percent”, “symbols”: [ [ “BOATS:WINT|1D” ] ], “dateRanges”: [ “1d|1”, “1m|30”, “3m|60”, “12m|1D”, “60m|1W”, “all|1M” ], “fontSize”: “10”, “headerFontSize”: “medium”, “autosize”: false, “width”: 800, “height”: 400, “noTimeScale”: false, “hideDateRanges”: false, “hideMarketStatus”: false, “hideSymbolLogo”: false }